MRK is down 3.21% today. Volume is 13.09M vs a 30-day average of 10.20M (1.28x).
Merck & Company, Inc. is scheduled to report earnings Thu, Oct 29, 2026 · before open. Analysts expect EPS of $2.10 on revenue of about $17.49B. Stocks often move sharply on earnings day.
Merck & Co., Inc. (NYSE:MRK) outlined new oncology data and development plans at the European Society for Medical Oncology annual meeting, highlighting phase III results for its s…
2026-10-26. The following slide deck was published by Merck & Co., Inc.
Merck & Co., Inc. (MRK) Shareholder/Analyst Call October 26, 2026 2:30 PM EDTCompany ParticipantsPeter Dannenbaum - Vice President of Investor...
Merck’s updated fair value estimate has shifted to US$159.76, compared with US$155.68 previously, which effectively nudges implied price targets higher for investors tracking intr…
Merck (NYSE:MRK) faces new U.S. Treasury restrictions on collaborations with certain Chinese biotech and AI firms announced in October 2026. This policy move targets U.S. investme…